The Homeiku Foundation, Which Provides the “Praise and Raise” Educational Method to More Than 500,000 People in 18 Countries Around the World, Published Their Book in Spain, Kickstarting Mutual Praise Service Between Countries
10.5.2022 12:41:00 EEST | Business Wire | Press release
The Homeiku {Ho-May-E-ku} Foundation has published its first book (titled "El libro de las alabanzas") in Spain. The foundation has provided the Homeiku method of nurturing people through praise to more than 500,000 people in 18 countries around the world. With the publication of the book in Spain and the launch of their services overseas, the foundation aims to further spread their mission of "making people in 196 countries shine through the Homeiku method."
Homeiku is an abbreviation for "Praise Education", which is a Japanese educational method that has been perfected through the combined studies of brain science and psychology along with the educational experience that Mr. Hara has cultivated over the years. This intrinsic method aims to support mental development by educating each individual to maximize their abilities through the power of “praise words”, with the ultimate goal for one to achieve self-fulfillment.
More than 400 companies have implemented Homeiku in their businesses, and the recognition of Homeiku's success around the world has led to the publication of the book in Spain. The content, which was published in Japan in December 2016 and has been a huge hit with 36,000 copies in 12 printings, has been translated into Spanish and localized for European culture.
The book consists of four sections: 1) The Amazing Power of Praise, 2) Praise that Reaches Others and Praise that Doesn't, 3) The 12 Rules for Becoming a Good Complimenter, and 4) How to Live a Life of Happiness through Praise. The book is designed to help couples, parents and children, friends, and colleagues improve their relationships with each other, and people who receive encouragement grow and create a cycle of happiness in their lives.
About the Homeiku Foundation:
The Homeiku Foundation was founded by Mr. Kunio Hara, who has since introduced his Praise method to more than 400 companies worldwide. Mr. Hara appeared twice at TEDx, authored 20 books (translated into English, Spanish, Chinese, and Korean), and is also a special advisor for the Council for the Promotion of National Education.
TEDx Videos:
https://www.youtube.com/watch?v=-oimrd7K59Q
https://www.youtube.com/watch?v=y5_vcu5fPAk
Publication URL:
https://www.esferalibros.com/libros/el-libro-de-las-alabanzas/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005436/en/
Contact information
Inquiries:
General Incorporated Association: Homeiku Foundation
Kaoru Sasazaki
info@spiral-up.jp
+81-6-6281-1226
https://homeiku.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration9.7.2026 16:00:00 EEST | Press release
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its already market-leading neuro offerings. The collaboration will begin with a focus on multiple sclerosis (MS), integrating quantitative MRI analysis from NeuroQuant MS directly into Viz.ai's care coordination workflow, giving clinicians both the quantitative precision and the coordination infrastructure needed to identify and manage MS patients at scale. “Viz.ai's core mission has always been to increase access to life-saving treatments. It’s about getting the right information to the right care tea
Orca Security Report: 99.9% of Fixable AI Vulnerabilities Remain Unpatched as AI Moves Into Production9.7.2026 16:00:00 EEST | Press release
Orca Security, a leader in cloud and AI security, today released its 2026 State of AI Security Report, offering a first-hand view into how AI is being deployed across more than 1,200 production cloud environments. The findings show AI is no longer limited to isolated pilots or developer experiments. Organizations are embedding AI into production applications, cloud services, and autonomous workflows faster than security programs can adapt. More than half (56%) of organizations have already deployed AI agents into production, while 51% use AI to build custom applications. At the same time, Orca found that 81% of organizations run vulnerable AI packages, and 99.9% of fixable AI vulnerabilities remain unpatched, highlighting how quickly AI has become operational infrastructure without corresponding security maturity. The report also reveals that AI environments are rapidly becoming more interconnected and business critical. Among organizations adopting AI, 64% now run vector databases, 55
Echodyne Opens New Manufacturing Facility to Meet Surging Global Demand for Advanced MESA® Radar9.7.2026 16:00:00 EEST | Press release
As governments around the world accelerate investment in counter-unmanned aircraft systems (C-UAS) and short-range air defense, Echodyne today announced the opening of a new advanced radar manufacturing facility in Washington State, significantly expanding its manufacturing capacity to meet rapidly growing demand from U.S. and allied customers. With millions of drones manufactured and used by both sides in the Russian War in Ukraine, the need for enhanced safety for defense, national security, and critical infrastructure assets grows with every successful strike and interception. The low cost and high utility of drones dramatically alters the need for safety and security sensors. And as the low altitude economy takes off, hundreds of thousands of drones will perform a range of life-saving and commercial missions, requiring a sensor infrastructure to monitor airspace activity. The new 86,350-square-foot facility is a major step in readying supply for multiple, large, global markets. The
SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 15:51:00 EEST | Press release
The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus ® (ocrelizumab) for Multiple Sclerosis9.7.2026 15:45:00 EEST | Press release
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260709701277/en/ “This agreement reflects our focus on pushing high-quality biologics to the finish line efficiently and at scale,” said Anjan Selz, Chief Executive Officer of Polpharma Biologics International AG. “Teva brings reach, discipline and real commercial strength to our strategic collaboration. Combining its global footprint with our technical and develo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom